4-[(5S)-5-(4,5-diethyl-2-methyl-1H-imidazol-1-yl)-2-(2-methoxyphenyl)-2,4,5,6-tetrahydrocyclopenta[c]pyrazol-3-yl]benzonitrile | 1566593-10-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 4-[(5S)-5-(4,5-diethyl-2-methyl-1H-imidazol-1-yl)-2-(2-methoxyphenyl)-2,4,5,6-tetrahydrocyclopenta[c]pyrazol-3-yl]benzonitrile
• 英文别名: 4-[(5S)-5-(4,5-diethyl-2-methyl-1H-imidazol-1-yl)-2-(2-methoxyphenyl)-2,4,5,6-tetrahydrocyclopenta[c]pyrazol-3-yl]benznitrile；4-[(5S)-5-(4,5-diethyl-2-methylimidazol-1-yl)-2-(2-methoxyphenyl)-5,6-dihydro-4H-cyclopenta[c]pyrazol-3-yl]benzonitrile
• CAS: 1566593-10-9
• 化学式: C₂₈H₂₉N₅O
• 分子量: 451.571
• InChiKey: FGTYJLBXVZOKDC-NRFANRHFSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.4
• 重原子数：
  34
• 可旋转键数：
  6
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  68.7
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• CYCLOPENTYLPYRAZOLES AS N-TYPE CALCIUM CHANNEL BLOCKERS
  申请人：Janssen Pharmaceutica NV

  公开号：US20140051660A1

  公开（公告）日：2014-02-20

  Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula (I) as follows: wherein R 1 , R 2 , R 3 , Q, and G are defined herein.
• US8853418B2
  申请人：——

  公开号：US8853418B2

  公开（公告）日：2014-10-07